NCT07320157

Brief Summary

Type of Study: This study was planned to be an observational study. Purpose of the Study: To evaluate the impact of HPV education given to women on their knowledge levels and HPV screening and vaccination.The main question\[s\] it aims to answer \[is/are\]: H1: There is a difference in the mean Human Papillomavirus (HPV) Knowledge Scale score between the intervention group women who participated in Human Papillomavirus (HPV) education and the control group women. H2: There is a difference between the intervention group women and the control group women in terms of their participation in HPV screening tests. H2: There is a difference between the intervention group women and the control group women in terms of their HPV vaccination status. Participants Participants will be assigned to a control and intervention group. Online training will be provided to the intervention group, and the results of the training will be reported.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
64

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jan 2026

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 19, 2025

Completed
18 days until next milestone

First Posted

Study publicly available on registry

January 6, 2026

Completed
3 days until next milestone

Study Start

First participant enrolled

January 9, 2026

Completed
14 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 23, 2026

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 3, 2026

Completed
Last Updated

January 22, 2026

Status Verified

January 1, 2026

Enrollment Period

14 days

First QC Date

December 19, 2025

Last Update Submit

January 20, 2026

Conditions

HPV (Human Papillomavirus)-AssociatedHPV Immunization Status

Keywords

HPVWOMENHEALTHVACCİNE

Outcome Measures

Primary Outcomes (1)

  • Change in HPV Knowledge Score

    Change in participants' HPV Knowledge Scale scores measured at baseline, first follow-up, and final follow-up. The measure evaluates the effect of the online education and brochure intervention compared to the control group.

    Baseline (before intervention), 2 weeks after brochure delivery (first follow-up), and 8 weeks after the first follow-up (final follow-up)

Secondary Outcomes (1)

  • Sustained HPV Knowledge Score (Knowledge Retention)

    Knowledge retention will be assessed by comparing HPV Knowledge Scale scores between groups at the final follow-up. Higher scores indicate better long-term retention of information provided by the intervention.

Study Arms (1)

Online Education Intervention Group

EXPERIMENTAL

An online training session will be scheduled for the intervention group. The training will consist of two 40-minute session. After the online training, the training materials will be shared with the group. One week after the training, an informational brochure prepared on the topic will be sent to the intervention group via WhatsApp as a reminder, and any questions they may have will be answered. Two weeks after delivering the brochure, the questionnaire/scale forms will be administered to both groups as the first follow-up. Eight weeks after the first follow-up, the same forms will be administered again as the post-test. The WhatsApp group will remain open and interaction will be allowed throughout the research period.

Behavioral: Online Education Intervention GroupOther: Contral Group

Interventions

Online Education Intervention GroupBEHAVIORAL

An online training session will be scheduled for the intervention group. The training will consist of two 40-minute session. After the online training, the training materials will be shared with the group. One week after the training, an informational brochure prepared on the topic will be sent to the intervention group via WhatsApp as a reminder, and any questions they may have will be answered. Two weeks after delivering the brochure, the questionnaire/scale forms will be administered to both groups as the first follow-up. Eight weeks after the first follow-up, the same forms will be administered again as the post-test. The WhatsApp group will remain open and interaction will be allowed throughout the research period.

Online Education Intervention Group
Contral GroupOTHER

No intervention will be applied to the control group. Following the completion of the study, the brochure prepared on the topic will be sent to them via WhatsApp.

Online Education Intervention Group

Eligibility Criteria

Age18 Years - 35 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsBecause the study evaluates an intervention related to cervical health, only female participants will be included.
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Being female
  • Women aged 18-35 years
  • Ability to speak and understand Turkish at a level sufficient to communicate with the researcher
  • Having the technical equipment necessary to participate in a video interview
  • No diagnosis of HPV positivity
  • Not having received the HPV vaccine
  • Not having undergone HPV DNA/Pap smear testing in the past 5 years
  • No diagnosis of cervical cancer
  • Voluntary willingness to participate in the study
  • No diagnosis of a psychiatric disorder

You may not qualify if:

  • Being male
  • Having severe physical or cognitive impairments that prevent completing the questionnaire
  • Being under 18 years of age or over 35 years of age
  • Inability to speak or understand Turkish
  • Lack of technical equipment to participate in a video interview
  • Having a diagnosis of HPV positivity
  • Having received the HPV vaccine
  • Having undergone HPV DNA/Pap smear testing in the past 5 years
  • Having a diagnosis of cervical cancer
  • Having a diagnosed psychiatric disorder
  • Not agreeing to participate in the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

UfUk UNİVERSİTY

Ankara, Ankara, 06000, Turkey (Türkiye)

RECRUITING

MeSH Terms

Conditions

Papillomavirus Infections

Condition Hierarchy (Ancestors)

Sexually Transmitted Diseases, ViralSexually Transmitted DiseasesCommunicable DiseasesInfectionsDNA Virus InfectionsVirus DiseasesTumor Virus InfectionsGenital DiseasesUrogenital DiseasesDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Central Study Contacts

GİZEM B BİLMEZ GİZEM, PHD STUDENT

CONTACT

905532657387gzm_erdogan@hotmail.com

Duygu Akçay, Assistant Professor (PhD)

CONTACT

+905055947466dakcay2010@hotmail.com

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
PREVENTION
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

December 19, 2025

First Posted

January 6, 2026

Study Start

January 9, 2026

Primary Completion

January 23, 2026

Study Completion

April 3, 2026

Last Updated

January 22, 2026

Record last verified: 2026-01

Data Sharing

IPD Sharing
Will not share

Due to privacy and confidentiality concerns of the participants, individual participant data will not be shared.

Locations

TU(1)